BORRELIOOSIN HOITO: UUSI VALMISTE KEHITTEILLÄ

[Bb]

Lähettäjä: Soijuv Lähetetty: 7.2.2006 11:40

Knock-Out Technologies ilmoittaa kehittävänsä parhaillaan uutta valmistetta borrelioosiin. Valmistajan mukaan valmiste on turvallinen, luonnollinen ja sitä otetaan suun kautta. Muuta tietoa ei ole tällä hetkellä. Valmistetta aloitetaan testata ihmisillä noin kuukauden kuluttua.

Kerron aiheesta lisää, kun siitä on saatavissa tietoa. Mikäli tuote on vakavasti otettavissa, laitan siitä selvityksen kotisivuillemme borrelioosin hoitoa käsitteleviin artikkeleihin.


http://www.genengnews.com/news/bnitem.a ... NEWSML.xml

eFoodSafety.com, Inc. Subsidiary, Knock-Out Technologies, Ltd. Readies Third Ingestible Product for Independent Laboratory Testing; New Knock-Out Formula Targets Lyme Disease
2/6/2006 9:30:00 AM EST
Robert Bowker, President/CEO of Knock-Out Technologies, Ltd., a wholly owned subsidiary of eFoodSafety.com, Inc. (OTCBB:EFSF), announced today that the company has created a safe, natural, ingestible product that can eradicate Lyme disease.

The company anticipates commencing human clinical trials using the Lyme disease product within the next 30 days. Human clinical trials have already commenced on the first ingestible product, the Avian Influenza formula. The second ingestible product, the Candida Albicans formula, which kills the most common fungal infection in immunosuppressed patients, is scheduled to undergo human clinical trials shortly.

Lyme disease is caused by the bacterium Borrelia burgdorferi and is transmitted to humans by the bite of infected blacklegged ticks. Typical symptoms include fever, headache, fatigue, and a characteristic skin rash called erythema migrans. If left untreated, infection can spread to joints, the heart, and the nervous system. Lyme disease is diagnosed based on symptoms, physical findings (e.g., rash), and the possibility of exposure to infected ticks; laboratory testing is helpful in the later stages of disease. The ticks that transmit Lyme disease can occasionally transmit other tick-borne diseases as well (Division of Vector-Borne Infectious Diseases; National Center for Infectious Diseases; Centers for Disease Control and Prevention; http://www.cdc.gov).

"Based on the increasing incidence of Lyme disease and its prolonged debilitating symptoms, we feel our product will have a major impact on this serious health threat. We will pursue human clinical trials to prove our groundbreaking technology is effective in eradicating Lyme disease," stated Patricia Ross-Gruden, President and CEO of eFoodSafety.com, Inc.

About eFoodSafety.com, Inc.
eFoodSafety.com, Inc. is dedicated to improving food and health conditions around the world through its innovative technologies. The company's Knock-Out Technologies, Ltd. subsidiary has developed an environmentally safe sporicidal product formulated entirely of food-grade components that eradicates anthrax and a germicidal product, Big 6 Plus -- EPA Reg. No. 82723-1 that kills six major bacteria: E-coli, Listeria, Pseudomonas, Salmonella, Staphylococcus, and Streptococcus, Avian Influenza, and Black Mold. The sporicidal product has completed its final efficacy laboratory study requisite for EPA registration. In the study, it eradicated both Clostridium Sporogenes and Bacillus Subtilis with 100% efficacy on both hard and porous surfaces. The company's MedElite, Inc. subsidiary distributes clinically proven products to physicians who then prescribe the products for their patients. It is the exclusive U.S. and worldwide distributor of the Talsyn(TM)-CI/bid Scar Cream that has been clinically proven to facilitate and improve the appearance, redness and strength of scars (www.talsyn.com). The company is also is a distributor for Cinnergen(TM), a non-prescription liquid whole food nutritional supplement that promotes healthy glucose metabolism (www.cinnergen.com), and most recently became a distributor for Trimmendous(TM), a weight loss formula focusing on the body's 24-hour metabolic processes.

Safe Harbor Forward-Looking Statements
Statements contained in this release that are not strictly historical are "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933 as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements are made based on information available as of the date hereof, and the company assumes no obligation to update such forward-looking statements. Editors and investors are cautioned that such forward-looking statements invoke risk and uncertainties and the company's actual results may differ from these forward-looking statements. Such risks and uncertainties include but are not limited to demand for the company's products and services, our ability to continue to develop markets, general economic conditions, our ability to secure additional financing for the company and other factors that may be more fully described in reports to shareholders and periodic filings with the Securities and Exchange Commission.

CONTACT:
Redwood Consultants, LLC Jens Dalsgaard, 415-884-0348